HealthLeap raises $38M from Sequoia to bring real-time AI disease screening to hospitals, starting with malnutrition

HealthLeap has raised $38M backed by Sequoia to deploy real-time AI disease screening across hospital populations, starting with malnutrition.

What it does

The platform monitors incoming patient records continuously, flagging undiagnosed or late-detected conditions so clinicians can intervene earlier. Meyer describes the value as threefold: better patient outcomes, more efficient use of clinical time, and accurate reimbursement for hospitals that aren't currently capturing the true severity of their patient population. The underlying logic is that earlier detection keeps patients healthier and drives down total care costs, even as hospitals get paid appropriately for complexity they were previously missing.

“Today, we're announcing $38 million backed by Sequoia. Having this high precision real-time risk screening for every patient every day across all major health conditions allows patients to get better care, clinicians to allocate their time more effectively, and hospitals also get paid for the actual appropriate severity in their population.”

Founding story

Meyer grew up in South Africa unable to afford health care. He represented the country at an international math competition as a teenager, funded the trip by winning chess tournaments, and used profits to cover his own medical costs. He eventually teamed up with his sister, a clinician specializing in clinical nutrition, and they identified disease-related malnutrition as the first condition to target. HealthLeap has since expanded beyond that initial focus.

Go-to-market

Sales cycles in healthcare are historically slow, so HealthLeap front-loads proof. Before asking a health system to commit, the company runs a backtested simulation showing what deployment would have caught, then contractually goes at risk on outcomes. Word of mouth among hospitals has accelerated pipeline: two weeks before the interview, a pain medicine department presented HealthLeap results at one of the largest healthcare conferences, generating a wave of inbound interest. Meyer notes that hospitals are geographically non-competitive and culturally inclined to share, which makes conference-driven referrals unusually effective in this market.

Sequoia is the lead investor. No valuation was disclosed.